BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15670879)

  • 1. Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.
    Danilova E; Shiryayev A; Skogen V; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Feb; 23(12):1446-50. PubMed ID: 15670879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response to booster vaccination against diphtheria toxin at age 18-21 years.
    Nahum E; Lerman Y; Cohen D; Salpon R; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):600-3. PubMed ID: 8045740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diphtheria booster immunization for adults].
    Hasselhorn HM; Nübling M; Tiller FW; Hofmann F
    Dtsch Med Wochenschr; 1997 Mar; 122(10):281-6. PubMed ID: 9102270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diphtheria antitoxin level 2 years after booster vaccination].
    Nicolay U; Girgsdies OE; Banzhoff A; Hundt E; Kondler-Budde R; Lober R; Hainz R; Jilg W
    Wien Med Wochenschr; 2000; 150(22):435-9. PubMed ID: 11191952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to diphtheria booster vaccine in the Baltic states.
    Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
    J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of immunity level against diphtheria and reinforcement of immunity by booster vaccination for infection control staff in Okayama prefecture.
    Nakajima H; Kariya H; Ohata R; Ogura H
    Jpn J Infect Dis; 2008 Mar; 61(2):104-6. PubMed ID: 18362396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.
    Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Oct; 23(42):4980-3. PubMed ID: 15985319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity against diphtheria and tetanus in the adult Polish population].
    Walory J; Grzesiowski P; Hryniewicz W
    Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?
    Olander RM; Auranen K; Härkänen T; Leino T
    Vaccine; 2009 Aug; 27(39):5295-8. PubMed ID: 19596410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
    Frank JW; Schabas R; Arshinoff R; Brant R
    CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations.
    Bissumbhar B; Rakhmanova AG; Berbers GA; Iakolev A; Nosikova E; Melnick O; Ovtcharenko E; Rümke HC; Ruitenberg EJ
    Vaccine; 2004 May; 22(15-16):1886-91. PubMed ID: 15121299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
    Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
    Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
    Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women.
    Bonetti TC; Succi RC; Weckx LY; Tavares-Lopes L; de Moraes-Pinto MI
    Vaccine; 2004 Sep; 22(27-28):3707-12. PubMed ID: 15315850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions.
    Khetsuriani N; Music S; Deforest A; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S208-12. PubMed ID: 10657216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.